Menu
HHS Secretary Robert F. Kennedy Jr. (center), CMS Administrator Mehmet Oz (right) and FDA Commissioner Marty Makary (left) announced biosimilar reform plans at a Wednesday HHS news conference.

Trump Administration to Accelerate Biosimilar Development; PhRMA Points to PBMs, 340B Program for Slow Uptake

Shannon Young, Associate Editor/Senior Writer 340B Report Views
Federal health officials on Wednesday announced new biosimilar reform efforts, which aim to more quickly and cheaply develop the lower [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Post Navigation

Is Your 340B Partner a Good Fit? Look for These Signs

House Lawmakers in Talks to Launch Bipartisan 340B Working Group as Counterpart to Senate ‘Gang of Six’

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Quick verification required before signup

Site Footer Live